ChatGPT takes on doctors in patient Q&A showdown

NCT ID NCT07202286

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compared how well an AI chatbot (ChatGPT) answered common questions from people with knee or hip osteoarthritis versus answers from real doctors. 286 patients rated the responses for preference, length, and difficulty. The goal was to see if AI could provide acceptable and accurate information to support patient education.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could show that AI chatbots can provide helpful, clear answers to common patient questions, potentially easing the burden on healthcare providers.
What could go wrong
This is a small, completed observational study, not a treatment trial. It only looked at patient preferences for answers, not actual health outcomes. Results may not apply to other conditions or AI models.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

286 people

The number who actually took part.

Started

May 2024

Finished

Jun 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

There were two groups of participants: 1) a panel of people with OA evaluating the preference, length, and difficulty, and 2) a panel of experts in the field of OA evaluating the accuracy of the responses

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * all individuals visiting the Department of Orthopedics in the Canisius Wilhelmina Hospital, a district general hospital in Nijmegen, The Netherlands, diagnosed with knee or hip OA between March 2023 and March 2024 Exclusion Criteria: * partly completion of the questionnaire

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acceptability are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Canisius Wilhelmina Hospital

    Nijmegen, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.